As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CVS Health: Union Square Park Capital Management LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Sig Brokerage LP, Royal Bank of Canada, Nomura Holdings Inc., Maven Securities LTD, Millennium Management LLC, Jefferies Financial Group Inc., Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Caption Management LLC, Centiva Capital LP, Capstone Investment Advisors LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Bank of America Corp DE, BNP Paribas Financial Markets, Jane Street Group LLC, Lido Advisors LLC, Tudor Investment Corp ET AL, Parallax Volatility Advisers L.P., Symmetry Investments LP, Susquehanna International Group LLP, HAP Trading LLC, Concourse Financial Group Securities Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Dymon Asia Capital Singapore PTE. LTD., Capital Fund Management S.A., DRW Securities LLC, Bank of Nova Scotia, Bank of Montreal Can, Wells Fargo & Company MN, JPMorgan Chase & Co., Simplex Trading LLC, Twin Tree Management LP, Oak Hill Wealth Advisors LLC, Allianz Asset Management GmbH, Wolverine Asset Management LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.